Molecular and Cellular Endocrinology 105131137
Such effects are consistent with their established reduction in atherosclerotic cardiovascular events and may be particularly relevant in patients with obesity, insulin resistance, or HFpEF phenotypes, and taken together, these mechanistic differences provide a biologically plausible rationale for combination therapy: SGLT2 inhibitors primarily target HF-related hemodynamic and cardiorenal pathways, whereas GLP-1 receptor agonists may further improve metabolic and vascular risk
Dimitriadis G, Mitrou P, Lambadiari V, Maratou E, Raptis SA
One bottle
there is currently insufficient research to confirm that creatine supplementation is safe while breastfeeding , so most healthcare providers recommend erring on the side of caution and consulting your doctor before adding it to your postpartum routine
A plausible cause for these phenomena could be a difference in kinetic parameters by the bacterium-host combination